Skip to main content
SpringerLink
Log in

Intensivmedizinisches Management hämatologischer und onkologischer Patienten

  • topic 1_Intensivmedizin
  • Published:
best practice onkologie Aims and scope

Jeder sechste Patient auf deutschen Intensivstationen hat eine Tumorerkrankung. Trotzdem besteht eine große Unsicherheit hinsichtlich der Indikationsstellung, der Therapiedauer und des Umfangs der Intensivtherapie. Während in onkologischen Zentren die Aufnahme palliativer Patienten zur zeitlich limitierten Therapie häufig etabliert ist, kann andernorts die Diagnose „Krebs“ zur Verweigerung der Aufnahme auf die Intensivstation führen. Vor dem Hintergrund der zunehmenden Zahl an Menschen, die mit einer Tumorerkrankung leben, der raschen Entwicklung von Krebstherapeutika mit unerwarteten und z. T. dramatischen Nebenwirkungen sowie der Verbesserung der Prognose von Patienten mit Zwei- oder Mehrorganversagen ist die Entwicklung von Aufnahme- und Therapiealgorithmen für kritisch kranke Tumorpatienten dringend geboten.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Sculier JP (1991) Intensive care in the treatment of cancer patients. Curr Opin Oncol 3:656–662

    CAS  PubMed  Google Scholar 

  2. Taccone FS, Artigas AA, Sprung CL et al (2009) Characteristics and outcomes of cancer patients in European ICUs. Crit Care 13:R15

    Article  PubMed Central  PubMed  Google Scholar 

  3. Lecuyer L, Chevret S, Thiery G (2007) The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 35:808–814

    Article  PubMed  Google Scholar 

  4. Azoulay E, Mokart D, Pene F et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—A Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique Study. J Clin Oncol (im Druck)

  5. Azoulay E, Mokart D, Lambert J et al (2010) Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 182:1038–1046

    Article  PubMed  Google Scholar 

  6. Azoulay E, Schlemmer B (2006) Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 32:808–822

    Article  PubMed  Google Scholar 

  7. Antonelli M, Conti G, Bufi M et al (2000) Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA 283:235–241

    Article  CAS  PubMed  Google Scholar 

  8. Wermke M, Schiemanck S, Hoffken G et al (2012) Respiratory failure in patients undergoing allogeneic hematopoietic SCT — a randomized trial on early non-invasive ventilation based on standard care hematology wards. Bone Marrow Transplant 47:574–580

    Article  CAS  PubMed  Google Scholar 

  9. Adda M, Coquet I, Darmon M et al (2008) Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 36:2766–2772

    Article  PubMed  Google Scholar 

  10. Gristina GR, Antonelli M, Conti G et al (2011) Noninvasive versus invasive ventilation for acute respiratory failure in patients with hematologic malignancies: a 5-year multicenter observational survey. Crit Care Med 39:2232–2239

    Article  PubMed  Google Scholar 

  11. Depuydt PO, Benoit DD, Roosens CD et al (2010) The impact of the initial ventilatory strategy on survival in hematological patients with acute hypoxemic respiratory failure. J Crit Care 25:30–36

    Article  PubMed  Google Scholar 

  12. Lengfelder E, Hofmann WK, Nolte F (2013) Management of elderly patients with acute promyelocytic leukemia: progress and problems. Ann Hematol (im Druck)

  13. Lecuyer L, Chevret S, Guidet B et al (2008) Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J 32:748–754

    Article  CAS  PubMed  Google Scholar 

  14. Hill QA, Kelly RJ, Patalappa C et al (2012) Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study. Leuk Lymphoma 53:282–288

    Article  PubMed  Google Scholar 

  15. Gruson D, Vargas F, Hilbert G et al (2004) Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia. Intensive Care Med 30:965–971

    Article  PubMed  Google Scholar 

  16. Peigne V, Rusinova K, Karlin L et al (2009) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 35:512–518

    Article  PubMed  Google Scholar 

  17. Squadrone V, Massaia M, Bruno B et al (2010) Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Med 36:1666–1674

    Article  PubMed  Google Scholar 

  18. Smith TJ, Temin S, Alesi ER et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30:880–887

    Article  PubMed  Google Scholar 

  19. Anderson WG, Arnold RM, Angus DC, Bryce CL (2008) Posttraumatic stress and complicated grief in family members of patients in the intensive care unit. J Gen Intern Med 23:1871–1876

    Article  PubMed Central  PubMed  Google Scholar 

  20. Coiffier B, Altman A, Pui CH et al (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26:2767–2778

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik I für Innere Medizin, Universitätsklinikum Köln und Centrum für Integrierte Onkologie Köln-Bonn, Kerpener Str. 62, 50937, Köln, Deutschland

    M. von Bergwelt-Baildon, A. Shimabukuro-Vornhagen, M. Hallek & M. Kochanek

Authors
  1. M. von Bergwelt-Baildon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Shimabukuro-Vornhagen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Hallek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Kochanek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. von Bergwelt-Baildon.

Additional information

Einhaltung ethischer Richtlinien

Interessenkonflikt. M. von Bergwelt-Baildon, M. Kochanek und A. Shimabukuro-Vornhagen geben an, dass kein Interessenkonflikt besteht. M. Hallek: Roche + Celgene: Honoria, Consultancy, Research, Funding.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

von Bergwelt-Baildon, M., Shimabukuro-Vornhagen, A., Hallek, M. et al. Intensivmedizinisches Management hämatologischer und onkologischer Patienten. best practice onkologie 9, 22–28 (2014). https://doi.org/10.1007/s11654-014-0516-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11654-014-0516-z

Search

Navigation